Tislelizumab plus platinum and etoposide versus placebo plus platinum and etoposide as first-line treatment for extensive-stage small-cell lung cancer: patient-reported outcomes in the RATIONALE-312 trial. - Cheng Y; Qin T; Chen C; B Barnes F; Barnes G (Current medical research and opinion, 2025)